Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 4/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7371294 | 0.85 | ALDH1A1 (0.60) | HPGDSMN1; SMN2ALDH1A1LMNAMAPK8 | |
| SCHEMBL7317640 | 0.84 | MAPK8 (0.75) | HPGDSMN1; SMN2LMNAMAPK8KMT2A | |
| SCHEMBL2484887 | 0.84 | — | — | |
| SCHEMBL7366928 | 0.83 | MAPK8 (0.55) | MAPK8POLBKMT2A | |
| SCHEMBL7375869 | 0.81 | PDE4A (0.61) | HPGDMAPK8KMT2AGAA | |
| SCHEMBL7365751 | 0.81 | MAPK8 (0.67) | MAPK8KMT2A | |
| SCHEMBL7369712 | 0.80 | MAPK8 (0.59) | MAPK8KMT2AGAA | |
| SCHEMBL7168843 | 0.80 | MAPK8 (0.72) | MAPK8KMT2AGAA | |
| SCHEMBL7371983 | 0.80 | MAPK8 (0.69) | HPGDSMN1; SMN2LMNAMAPK8KMT2A | |
| SCHEMBL23412428 | 0.80 | HPGD (0.72) | HPGDSMN1; SMN2ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6380218-B1 | FOR THERAPY OF RESPIRATORY, ALLERGIC, AND INFLAMMATORY DISORDERS COMPRISING ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ACUTE RESPIRATORY DISEASE SYNDROME, PULMONARY HYPERSENSITIVITY, AND ALLERGIC RHINITIS IN A MAMMAL | PFIZER INC | 2002-04-30 | — | — | US | disclosed |
| EP-0971894-A1 | NICOTINAMIDE DERIVATIVES | Pfizer Products Inc. (US) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998045268-A1 | NICOTINAMIDE DERIVATIVES | PFIZER PRODUCTS INC. (US) | 1998-10-15 | — | — | WO | disclosed |